BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35838333)

  • 1. Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome.
    Viktorsson K; Hååg P; Shah CH; Franzén B; Arapi V; Holmsten K; Sandström P; Lewensohn R; Ullén A
    Mol Oncol; 2022 Oct; 16(20):3620-3641. PubMed ID: 35838333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells.
    Boddu VK; Zamzow P; Kramer MW; Merseburger AS; Gorantla SP; Klinger M; Cramer L; Sauer T; Gemoll T; von Bubnoff N; Gieseler F; Darabi M
    Cell Commun Signal; 2024 Feb; 22(1):129. PubMed ID: 38360687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial.
    Shah CH; Pappot H; Agerbæk M; Holmsten K; Jäderling F; Yachnin J; Grybäck P; von der Maase H; Ullén A
    Oncologist; 2019 Jun; 24(6):745-e213. PubMed ID: 30552156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles expressing CEACAM proteins in the urine of bladder cancer patients.
    Igami K; Uchiumi T; Shiota M; Ueda S; Tsukahara S; Akimoto M; Eto M; Kang D
    Cancer Sci; 2022 Sep; 113(9):3120-3133. PubMed ID: 35611462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients.
    Jingushi K; Kawashima A; Saito T; Kanazawa T; Motooka D; Kimura T; Mita M; Yamamoto A; Uemura T; Yamamichi G; Okada K; Tomiyama E; Koh Y; Matsushita M; Kato T; Hatano K; Uemura M; Tsujikawa K; Wada H; Nonomura N
    Cancer Immunol Immunother; 2022 Dec; 71(12):2999-3011. PubMed ID: 35598195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicles transmitted miR-31-5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma.
    He J; He J; Min L; He Y; Guan H; Wang J; Peng X
    Int J Cancer; 2020 Feb; 146(4):1052-1063. PubMed ID: 31259424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond-A Comprehensive Review of the Current Literature.
    Oing C; Rink M; Oechsle K; Seidel C; von Amsberg G; Bokemeyer C
    J Urol; 2016 Feb; 195(2):254-63. PubMed ID: 26410730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bempegaldesleukin plus Nivolumab in First-line Metastatic Urothelial Carcinoma: Results from PIVOT-02.
    Siefker-Radtke AO; Cho DC; Diab A; Sznol M; Bilen MA; Balar AV; Grignani G; Puente E; Tang L; Chien D; Hoch U; Choudhury A; Yu D; Currie SL; Tagliaferri MA; Zalevsky J; Hurwitz ME; Tannir NM
    Eur Urol; 2022 Oct; 82(4):365-373. PubMed ID: 35643589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-translational protein deimination signatures in sea lamprey (Petromyzon marinus) plasma and plasma-extracellular vesicles.
    Rast JP; D'Alessio S; Kraev I; Lange S
    Dev Comp Immunol; 2021 Dec; 125():104225. PubMed ID: 34358577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and analysis of tumor‑derived extracellular vesicles from head and neck squamous cell carcinoma plasma by galectin‑based glycan recognition particles.
    Benecke L; Chiang DM; Ebnoether E; Pfaffl MW; Muller L
    Int J Oncol; 2022 Nov; 61(5):. PubMed ID: 36129151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct profile of CD34
    Forte D; Barone M; Morsiani C; Simonetti G; Fabbri F; Bruno S; Bandini E; Sollazzo D; Collura S; Deregibus MC; Auteri G; Ottaviani E; Vianelli N; Camussi G; Franceschi C; Capri M; Palandri F; Cavo M; Catani L
    J Exp Clin Cancer Res; 2021 Feb; 40(1):49. PubMed ID: 33522952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma.
    Chen S; Zhang N; Wang T; Zhang E; Wang X; Zheng J
    Front Immunol; 2020; 11():1900. PubMed ID: 32983112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large Extracellular Vesicles Can be Characterised by Multiplex Labelling Using Imaging Flow Cytometry.
    Johnson SM; Banyard A; Smith C; Mironov A; McCabe MG
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of extracellular vesicles secreted by primary human epithelial endometrial cells reveals key proteins related to embryo implantation.
    Segura-Benítez M; Carbajo-García MC; Corachán A; Faus A; Pellicer A; Ferrero H
    Reprod Biol Endocrinol; 2022 Jan; 20(1):3. PubMed ID: 34980157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
    Andreu Z; Otta Oshiro R; Redruello A; López-Martín S; Gutiérrez-Vázquez C; Morato E; Marina AI; Olivier Gómez C; Yáñez-Mó M
    Eur J Pharm Sci; 2017 Feb; 98():70-79. PubMed ID: 27751843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct.
    Xu R; Greening DW; Rai A; Ji H; Simpson RJ
    Methods; 2015 Oct; 87():11-25. PubMed ID: 25890246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Artificial Intelligence and Machine Learning Algorithms with Gene Expression Profiling to Predict Recurrent Nonmuscle Invasive Urothelial Carcinoma of the Bladder.
    Bartsch G; Mitra AP; Mitra SA; Almal AA; Steven KE; Skinner DG; Fry DW; Lenehan PF; Worzel WP; Cote RJ
    J Urol; 2016 Feb; 195(2):493-8. PubMed ID: 26459038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis.
    Pasetto L; Callegaro S; Corbelli A; Fiordaliso F; Ferrara D; Brunelli L; Sestito G; Pastorelli R; Bianchi E; Cretich M; Chiari M; Potrich C; Moglia C; Corbo M; Sorarù G; Lunetta C; Calvo A; Chiò A; Mora G; Pennuto M; Quattrone A; Rinaldi F; D'Agostino VG; Basso M; Bonetto V
    Mol Neurodegener; 2021 Aug; 16(1):52. PubMed ID: 34376243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis.
    Zhu Q; Li H; Ao Z; Xu H; Luo J; Kaurich C; Yang R; Zhu PW; Chen SD; Wang XD; Tang LJ; Li G; Huang OY; Zheng MH; Li HP; Liu F
    J Nanobiotechnology; 2022 Jul; 20(1):349. PubMed ID: 35897102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
    Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
    Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.